• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E2F1在p210 BCR-ABL下游对c-myc转录起始的调控作用。对小鼠骨髓细胞的研究。

Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells.

作者信息

Stewart M J, Litz-Jackson S, Burgess G S, Williamson E A, Leibowitz D S, Boswell H S

机构信息

Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, USA.

出版信息

Leukemia. 1995 Sep;9(9):1499-507.

PMID:7658719
Abstract

Experiments were performed to elucidate the mechanism through which p210 BCR-ABL, by its downstream signals, regulates c-myc messenger RNA expression in hematopoietic cells. We studied a model system in which stable expression of p210 BCR-ABL in interleukin-3 (IL-3) dependent murine myeloid cell lines led to growth factor independent transformation. Active c-myc transcription was observed in p210 BCR-ABL transformed cells by nuclear run-on assay, and in heterologous reporter assays performed with the 5' regulatory region of murine c-myc linked to firefly luciferase. Transcription initiation occurred primarily from the P2 promoter in p210 BCR-ABL transformed cells. Cis and trans elements responsible for transcription initiation from the c-myc P2 promoter were studied. Expression of E2F1 protein in p210 BCR-ABL transformed cells accounted, in part, for binding to the E2F site of the P2 c-myc promoter. The functional importance of E2F1 expression in p210 BCR-ABL transformed cells toward c-myc transcription was established in reporter assays performed with the P2 c-myc promoter containing either wild-type or mutant E2F sites. Mutation of the E2F motif of P2 5' c-myc reduced activity of the promoter by 50%. By gel mobility shift, E2F1 was found in P2 c-myc band shift complexes along with the cyclin-dependent kinase 2. Therefore, coupling of E2F to components of the retinoblastoma-cyclin pathway defines a route from p210 BCR-ABL to c-myc transcription, which is required for p210 BCR-ABL transformation.

摘要

开展实验以阐明p210 BCR-ABL通过其下游信号调节造血细胞中c-myc信使核糖核酸表达的机制。我们研究了一个模型系统,其中p210 BCR-ABL在依赖白细胞介素-3(IL-3)的小鼠髓系细胞系中的稳定表达导致了生长因子非依赖性转化。通过核转录分析在p210 BCR-ABL转化细胞中观察到活跃的c-myc转录,并且在用与萤火虫荧光素酶相连的小鼠c-myc的5'调控区进行的异源报告基因分析中也观察到了这种转录。转录起始主要发生在p210 BCR-ABL转化细胞中的P2启动子。研究了负责从c-myc P2启动子起始转录的顺式和反式元件。p210 BCR-ABL转化细胞中E2F1蛋白的表达部分解释了其与P2 c-myc启动子的E2F位点的结合。在用含有野生型或突变型E2F位点的P2 c-myc启动子进行的报告基因分析中确定了p210 BCR-ABL转化细胞中E2F1表达对c-myc转录的功能重要性。P2 5' c-myc的E2F基序突变使启动子活性降低了50%。通过凝胶迁移率变动分析,发现E2F1与细胞周期蛋白依赖性激酶2一起存在于P2 c-myc条带迁移复合物中。因此,E2F与视网膜母细胞瘤-细胞周期蛋白途径的成分的偶联定义了一条从p

相似文献

1
Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells.E2F1在p210 BCR-ABL下游对c-myc转录起始的调控作用。对小鼠骨髓细胞的研究。
Leukemia. 1995 Sep;9(9):1499-507.
2
p120-v-Abl expression overcomes TGF-beta1 negative regulation of c-myc transcription but not cell growth.p120-v-Abl表达克服了转化生长因子-β1对c-myc转录的负调控,但并未克服对细胞生长的负调控。
Oncogene. 1996 Oct 3;13(7):1499-509.
3
Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.环磷酸腺苷(cAMP)对p210 BCR-ABL转化细胞中的c-myc转录和G1期细胞周期进程起负调控作用:通过细胞周期蛋白D1和细胞周期蛋白依赖性激酶4(cdk4)发挥抑制活性。
Leukemia. 1997 Jan;11(1):73-85. doi: 10.1038/sj.leu.2400551.
4
Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.通过ets家族蛋白和E2F-1靶向的单个DNA结合位点对myc表达进行双重调控。
Oncogene. 1994 Feb;9(2):405-15.
5
E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.人源MYC的E2F依赖性调控:细胞周期蛋白D1和A的反式激活作用超越肿瘤抑制蛋白功能。
Oncogene. 1994 Jul;9(7):2029-36.
6
A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.转录因子E2F在HL60细胞向粒细胞和巨噬细胞样分化过程中对c-myc基因表达的直接作用。
Cell Growth Differ. 1995 Mar;6(3):229-37.
7
Deregulation of specific E2F complexes by the v-mos oncogene.v-mos癌基因对特定E2F复合物的调控异常。
Oncogene. 1997 Jun 26;14(25):3029-38. doi: 10.1038/sj.onc.1201157.
8
Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.视网膜母细胞瘤蛋白(pRb)/E2F信号通路的破坏以及细胞凋亡的抑制是在持续表达c-myc和转化生长因子α的肝脏中发生的主要致癌事件。
Cancer Res. 1998 Jan 1;58(1):123-34.
9
Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.Sp1家族转录因子:与E2F的相互作用及对小鼠胸苷激酶启动子的调控
J Mol Biol. 1999 Nov 12;293(5):1005-15. doi: 10.1006/jmbi.1999.3213.
10
The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.神经酰胺诱导的c-myc转录的生长停滞和下调是与p21诱导、Rb低磷酸化和E2F隔离相关的事件。
Cell Death Differ. 1998 May;5(5):381-9. doi: 10.1038/sj.cdd.4400358.

引用本文的文献

1
The suppressive functions of Rora in B lineage cell proliferation and BCR/ABL1-induced B-ALL pathogenesis.Rora 在 B 细胞增殖和 BCR/ABL1 诱导的 B-ALL 发病机制中的抑制功能。
Int J Biol Sci. 2022 Mar 6;18(6):2277-2291. doi: 10.7150/ijbs.68939. eCollection 2022.
2
MCTS1 promotes the development of lung adenocarcinoma by regulating E2F1 expression.MCTS1通过调节E2F1表达促进肺腺癌的发展。
Oncol Lett. 2021 Jul;22(1):531. doi: 10.3892/ol.2021.12792. Epub 2021 May 17.
3
A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells.
一种新型萘醌-香豆素杂合物,可抑制BCR-ABL1-STAT5致癌通路并降低伊马替尼耐药慢性粒细胞白血病细胞的存活率。
Front Pharmacol. 2019 Jan 9;9:1546. doi: 10.3389/fphar.2018.01546. eCollection 2018.
4
-mediated regulation of E2F1 is required for CML stem/progenitor cell survival.E2F1 的介导调节对于 CML 干细胞/祖细胞的存活是必需的。
Blood. 2018 Apr 5;131(14):1532-1544. doi: 10.1182/blood-2017-05-783845. Epub 2018 Feb 5.
5
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene.BCR/ABL1和BCR受MYC癌基因的转录调控。
Mol Cancer. 2015 Jul 16;14:132. doi: 10.1186/s12943-015-0407-0.
6
Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients.第二代酪氨酸激酶抑制剂可预防高危(高 CIP2A)慢性髓性白血病患者的疾病进展。
Leukemia. 2015 Jul;29(7):1514-23. doi: 10.1038/leu.2015.71. Epub 2015 Mar 13.
7
Loss of the xeroderma pigmentosum group B protein binding site impairs p210 BCR/ABL1 leukemogenic activity.丧失着色性干皮病 B 组蛋白结合位点会损害 p210 BCR/ABL1 白血病发病活性。
Blood Cancer J. 2013 Aug 16;3(8):e135. doi: 10.1038/bcj.2013.36.
8
Synergy between proteasome inhibitors and imatinib mesylate in chronic myeloid leukemia.蛋白酶体抑制剂与甲磺酸伊马替尼在慢性髓性白血病中的协同作用。
PLoS One. 2009 Jul 16;4(7):e6257. doi: 10.1371/journal.pone.0006257.
9
Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis.通过核糖组学鉴定BCR/ABL癌蛋白新的转录后靶点:E2F3对BCR/ABL白血病发生的需求
Blood. 2008 Jan 15;111(2):816-28. doi: 10.1182/blood-2007-05-090472. Epub 2007 Oct 9.
10
Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21waf1/cip1 among human bronchogenic carcinomas.人支气管源性癌中细胞周期蛋白依赖性激酶抑制剂p21waf1/cip1转录调控的变异
Mol Cancer. 2005 Jul 13;4:23. doi: 10.1186/1476-4598-4-23.